Atlas Trials

A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer

Clinical trial NCT01836120 · UNKNOWN

Trial details

NCT number
NCT01836120
Sponsor
Hebei Tumor Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2013-04-01
Primary completion
2016-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.